• Lisa Sanderson Cox, Christi A Patten, Lois E Krahn, Richard D Hurt, Ivana T Croghan, Troy D Wolter, Darrell R Schroeder, Diane Tri, and Kenneth P Offord.
• Nicotine Research Center, Mayo Clinic, Rochester, MN 55905, USA.
• J Addict Dis. 2003 Jan 1; 22 (4): 75-85.

AbstractPrior uncontrolled studies of nonsmokers with major depressive disorder (MDD) indicate rapid reduction in depressive symptoms with nicotine patch therapy. This randomized, double-blind, placebo-controlled pilot study examined the effect of nicotine patch therapy on depressive symptoms in non-medicated nonsmokers with current MDD. Due to recruitment difficulties, only 7 were enrolled and of these 6 (5 females, 1 male) completed the study. Participants received either placebo (n = 4) or active (n = 2) patch therapy for 8 days. They completed daily clinic visits during patch therapy and a final visit on Day 12. Depressive symptoms were assessed using the Hamilton Rating Scale for Depression (HRSD). The mean change in HRSD scores of all participants decreased (p = 0.021) from baseline by Day 1 of patch use. Similar decreases in HRSD scores were observed for placebo and active patch groups. Among the placebo participants, the mean HRSD score decreased (p = 0.038) by Day 2. The study needs replication with a larger sample and utilizing novel recruitment strategies.

19 keywords...

hide…